Data from humans and animal models support a causative role for TNF-α in the pathogenesis of disorders such as alcoholic hepatitis, Crohn’s disease, rheumatoid arthritis, inflammatory bowel disease, and skin diseases, supporting the theoretical rationale for selective TNF inhibition as a beneficial treatment in those patients13, 14, 15, 16. This evidence concerns the gene TNF and alcoholic hepatitis.